AI-generated summary
The authors report a randomized, placebo-controlled, double-blinded trial of a 10 W class IV laser in 16 subjects with chronic epicondylitis, comparing laser treatment with a sham device. They report improvements in grip strength, function and pain in the laser group at 3, 6 and 12 months, with no adverse effects reported. The sham group also improved, and the authors conclude the laser was efficacious, though the trial was small.
- Participants
- 16
- Who or what was studied
- Subjects with chronic epicondylitis (chronic tendinopathy of the extensor carpi radialis brevis tendon)
- Wavelengths
- 980, 810 nm
- Limits stated in the abstract
- The trial was small, with only 16 subjects, and the sham group also showed improvements at 12 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Power
- 10 W, 0.5 W
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Sham, Photobiomodulation, Placebo-controlled, Power output, Tendinopathy, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.